Amdocs (NASDAQ:DOX) Director Yvette Kanouff Purchases 2,400 Shares of Company Stock

Amdocs Limited (NASDAQ:DOX) Director Yvette Kanouff bought 2,400 shares of Amdocs stock in a transaction dated Monday, November 9th. The stock was purchased at an average price of $42.00 per share, for a total transaction of $100,800.00. Following the purchase, the director directly owned 26,600 shares in the company, valued at $1,117,200. This represents a 9.92% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Amdocs Price Performance

Shares of DOX traded up $1.22 during trading hours on Thursday, hitting $44.34. The stock had a trading volume of 1,086,395 shares, compared to its average volume of 1,315,788. Amdocs Limited has a 52 week low of $39.96 and a 52 week high of $84.95. The stock has a market capitalization of $4.79 billion, a price-to-earnings ratio of 9.49, a P/E/G ratio of 1.35 and a beta of 0.42. The company’s fifty day moving average is $58.25 and its two-hundred day moving average is $61.37. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, November 3rd. The technology company reported $1.98 earnings per share for the quarter, hitting the consensus estimate of $1.98. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The firm had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.19 billion. During the same period in the prior year, the firm earned $1.83 earnings per share. The company’s quarterly revenue was up 3.8% compared to the same quarter last year. On average, analysts anticipate that Amdocs Limited will post 5.82 EPS for the current year.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be issued a dividend of $0.5690 per share. This represents a $2.28 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date of this dividend is Thursday, December 31st. Amdocs’s dividend payout ratio (DPR) is currently 48.61%.

Institutional Trading of Amdocs

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Trust Advisors LP lifted its position in Amdocs by 18.7% during the 3rd quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company’s stock valued at $93,652,000 after purchasing an additional 258,098 shares during the period. Advisors Asset Management Inc. bought a new stake in shares of Amdocs during the third quarter worth approximately $40,432,000. Composition Wealth LLC bought a new stake in shares of Amdocs during the third quarter worth approximately $309,000. Voya Investment Management LLC lifted its holdings in Amdocs by 155.6% in the third quarter. Voya Investment Management LLC now owns 28,213 shares of the technology company’s stock valued at $1,613,000 after buying an additional 17,173 shares during the period. Finally, Public Sector Pension Investment Board acquired a new position in Amdocs in the third quarter valued at approximately $3,281,000. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on DOX. Zacks Research lowered Amdocs from a “hold” rating to a “strong sell” rating in a research note on Monday. Stifel Nicolaus decreased their price objective on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Weiss Ratings upgraded shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 23rd. Oppenheimer downgraded shares of Amdocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 4th. Finally, Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $69.00.

Key Amdocs News

These are some of the DOX news items that stood out recently:

• Negative Sentiment: Multiple law firms have announced investigations into potential securities claims, citing allegations that Amdocs may have issued materially misleading business information. These are investigations, not findings of wrongdoing, but they could add reputational and legal uncertainty. Pomerantz investigation notice Rosen investigation notice
• Negative Sentiment: The central concern remains Amdocs’ fiscal 2027 outlook, reportedly weakened by an escalating T-Mobile dispute. The resulting disappointment was associated with a roughly 30% one-session share decline on November 4, despite quarterly results being in line with expectations. Levi & Korsinsky notice
• Negative Sentiment: Zacks Research downgraded Amdocs from “hold” to “strong sell,” adding to the cautious analyst sentiment. Zacks Research ratings

Amdocs Company Profile

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.